According to Apellis Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -356.37%. At the end of 2022 the company had an Operating Margin of -820.55%.
Year | Operating Margin | Change |
---|---|---|
2022 | -820.55% | -25.46% |
2021 | -1,100.85% | 781.29% |
2020 | -124.91% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 0.00% | N/A | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.